Supplement ArticlesFuture perspectives for cancer screeningViguier, Jérôme Author Information Coordination Center for Cancer Screening, Bretonneau University Hospital, Tours, France Correspondence to Jérôme Viguier, MD, Coordination Center for Cancer Screening, Bretonneau University Hospital, 2 Boulevard Tonnellé, 37044 Tours cedex 9, France Tel: +33 0 247 47 98 92; fax: +33 0 247 47 84 28; e-mail: [email protected] Received February 16, 2015 Accepted February 18, 2015 European Journal of Cancer Prevention 24():p S87-S89, July 2015. | DOI: 10.1097/CEJ.0000000000000142 Buy Metrics Abstract The past 20 years have seen major advances in screening for different cancer types. Screening is however destined to evolve, in terms of target populations, procedures used and the overall positioning of screening in the fight against the different forms of cancer. At the same time, screening is expected progressively to become more closely tailored to the level of risk; the type of tests and the frequency with which they are used will be adjusted in a more personalized approach. A critical issue is also to provide the population at large with more extensive information on the advantages and disadvantages, particularly of screening programmes known for the potentially high rate of overdiagnosis. These issues and their evolution are considered herein, in the context of screening for different forms of cancer (breast, prostate, colorectal, lung, cervical and melanoma). Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.